The prognostic value of hormone receptor detection by enzyme immunoassay and immunohistochemistry: A prospective study in patients with early breast cancer

International Journal of Biological Markers

Volumn 17, Issue 1, 2002, Pages 24-32

  Fiets, W E ^a   Blankenstein, M A ^a   Struikmans, H ^a   Ruitenberg, H M ^a   Nortier, J W R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Breast cancer; Enzyme immunoassay; Estrogen receptor; Immunocytochemistry; Progesterone receptor; Prognosis

Indexed keywords

HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXCISION; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; NEWBORN; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY;

EID: 0036217114     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.2752     Document Type: Article

References (25)

1. Tamoxifen for early breast cancer: An overview of the randomised trials
2. Meeting highlights: International consensus panel on the treatment of primary breast cancer
3. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers
4. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
5. Knapstein P-G. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): Prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC)
6. Comparative evaluation of ER-ICA and enzyme immunoassay for the quantitation of estrogen receptors in breast cancer
7. Estrogen receptor analysis: Correlation between enzyme immunoassay and immunohistochemical methods
8. A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification
9. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer
10. Comparison of ligand binding assay and enzyme immunoassay of oestrogen receptor in human breast cancer cytosols. Experience of the E.O.R.T.C. Receptor Group
11. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols
12. Estrogen and progesterone receptors in breast cancer: Comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay
13. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay
14. Comparison of immunocytochemical estrogen receptor assay, estrogen receptor enzyme immunoassay, and radioligand-labeled estrogen receptor assay in human breast cancer and uterine tissue
15. Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer
16. Cytological evaluation of biological prognostic markers from primary breast carcinomas
17. Comparison of monoclonal immunocytochemical and immunoenzymatic methods for steroid receptor evaluation in breast cancer
18. Prognostic significance of estrogen receptors in 405 primary breast cancers: A comparison of immunohistochemical and biochemical methods
19. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endorine therapy in breast cancer
20. Revision of the standards for the assessment of hormone receptors in human breast cancer
21. De betekenis van steroïdreceptoren voor de prognose en de hormonale behandeling van patiënten met mammacarcinoom: Een retrospectief onderzoek in Zuidoost-Nederland
22. Estrogen receptor negative and progesterone receptor positive primary breast cancer: Pathological characteristics and clinical outcome
23. Steroid hormone receptors in breast cancer management
24. Quantification of estrogen receptors on paraffin-embedded tumors by image analysis
25. Prognostic value of continuous variables in breast cancer and head and neck cancer. Dependence on the cut-off level